Form 4 for BHVN Biohaven Ltd.
Accepted 2022-10-26 00:00:00 ET · period of report 2022-10-25 · accession 0001562180-22-007332 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-10-26 | 2022-10-25 | BHVN | Coric Vlad | CEO, Dir | P - Purchase | $10.50 | +853.4K | 1.48M | +137% | +$8.96M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2022-10-25 | P | A | 853,380 | $10.50 | 1,475,664 | D | — | — | (F1) Represents common shares acquired in an underwritten public offering. |